Prevention of renal injury in diabetic MWF rats by angiotensin II antagonism

Experimental Nephrology

Volumn 6, Issue 1, 1998, Pages 28-38

  Remuzzi, Andrea ^a,c   Fassi, Annamaria ^a   Sangalli, Fabio ^a   Malanchini, Barbara ^a   Mohamed, Ehab I ^a   Bertani, Tullio ^a,b   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

^c MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Glomerular hypertension; Glomerular volume; Glomerulosclerosis; MWF rat; Proteinuria

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN II ANTAGONIST; BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLOMERULOSCLEROSIS; HYPERGLYCEMIA; HYPERTENSION; KIDNEY INJURY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; RAT; STREPTOZOCIN DIABETES;

EID: 0031907029     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020502     Document Type: Article

References (49)

1. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 1981; 241:F85-F93.
2. Hosteller TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 1982;72:375-380.
3. Simons JL, Provoost AP, Andersen S, Rennke HG, Troy JL, Brenner BM: Modulation of glomerular hypertension defines susceptibility to progressvie glomerular injury. Kidney Int 1994;46:396-404.
4. Meyer T, Baboolal K, Brenner BM: Nephron adaptation to renal injury; in Brenner BM (ed): The Kidney. Philadelphia, Saunders, 1996, pp 2011-2048.
5. Simons JL, Provoost AP, Anderson S, Troy JL, Rennke HG, Sandstrom DJ, Brenner BM: Pathogenesis of glomerular injury in the Fawn-Hooded rat: Early glomerular capillary hypertension predicts glomerular sclerosis. J Am Soc Nephrol 1993;3:1775-1782.
6. Remuzzi A, Puntorieri S, Alfano M, Macconi D, Abbate M, Bertani T, Remuzzi G: Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury. Lab Invest 1992;67:572-579.
7. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G: Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990;85: 541-549.
8. Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G: Discussion between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in the rat. Am J Physiol 1994;267:F1034-F1044.
9. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981;19:410-415.
10. Hirose K, Osterby R, Nozawa M, Gundersen HJG: Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 1982;21:689-695.
11. O'Donnell MP, Kasiske BL, Keane WF: Glomerular hemodynamic and structural alterations in experimental diabetes mellitus. FASEB 1992;2:2339-2347.
12. Michels LD, Davidman M, Keane WF: Determinants of glomerular filtration and plasma flow in experimental diabetic rats. J Lab Clin Med 1981;98:869-885.
13. Zatz R, Dunn BR, Meyer TW, Anderson S, Rennke HG, Brenner BM: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 1986;77:1925-1930.
14. Zatz R, Meyer TW, Rennke HG, Brenner BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985;82:5963-5967.
15. Remuzzi A, Perico N, Amuchastegui CS, Malanchini B, Mazerska M, Battaglia C, Bertani T, Remuzzi G: Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol 1993;4: 40-49.
16. Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G: Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats. Exp Nephrol 1996;4:19-25.
17. Read SM, Northcote DH: Minimization of variations in the response to different proteins of the Coomassie blue G dye-binding assay for protein. Anal Biochem 1981;116:53-64.
18. Deng A, Baylis C: Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am J Physiol 1993;33: F212-F215.
19. Lafayette RA, Mayer G, Park SK, Meyer TW: Angiotensin II blockade limits glomerular injury in rats with reduced renal mass. J Clin Invest 1992;90:766-771.
20. Ene-Iordache B, Imberti O, Foglieni C, Remuzzi G, Bertani T, Remuzzi A: Effects of angiotensin-converting enzyme inhibition on glomerular capillary wall ultrastructure in MWF/ Ztm rats. J Am Soc Nephrol 1994;5:1378-1384.
21. Weibel ER: Practical methods for biological morphometry. in Stereological Methods. London, Academic Press, 1979. Vol 1, pp 1-145.
22. Ichikawa I, Maddox DA, Cogan MG, Brenner BM: Dynamics of glomerular ultrafiltration in euvolemic Munich Wistar rats. Renal Physiol 1978;1:121-131.
23. Stackhouse S, Miller PL, Park SK, Meyer TW: Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats. J Am Soc Nephrol 1990; 39:1989-1990.
24. Remuzzi A, Benigni A, Malanchini B, Bruzzi I, Foglieni C, Remuzzi G: ACE inhibition prevents renal failure and death in uninephrectomized MWF/Ztm rats. Kidney Int 1995;47: 1319-1326.
25. Yoshioka T, Rennke HG, Salant DJ, Deen WM, Ichikawa I: Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A study in early passive Heymann nephritis. Circ Res 1987; 61:531-538.
26. Anderson S, Meyer TW, Rennke HG, Brenner BM: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985;76:612-619.
27. Zatz R, Andersen S, Meyer TW, Dunn BR, Rennke HG, Brenner BM: Lowering of arterial blood pressure limits glomerular sclerosis in rats with ablation and in experimental diabetes. Kidney Int 1987;31:S123-S129.
28. Dilley JR, Carradi A, Arendshorst WJ: Glomerular ultrafiltration dynamics during increased renal venous pressure. Am J Physiol 1983;13:F650-F658.
29. Olivetti G, Kithier K, Giacomelli F, Wiener J: Characterization of glomerular permeability and proteinuria in acute hypertension in the rat. Kidney Int 1984;25:599-607.
30. Yoshioka T, Mitrarai T, Kon V, Deen WM, Rennke HG, Ichikawa I: Role for angiotensin II in overt functional proteinuria. Kidney Int 1986;30:538-545.
31. Lapinski R, Perioc N, Remuzzi A, Sangalli F, Benigni A, Remuzzi G: Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney. J Am Soc Nephrol 1996;7:1-8
32. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990;38: 384-394.
33. Benigni A, Zoja C, Remuzzi G: The renal toxicity of sustained glomerular protein traffic. Lab Invest 1995;73:461-468.
34. Benigni A, Remuzzi G: Glomerular protein trafficking and progression of renal disease to terminal uremia. Semin Nephrol 1996;16:151-159.
35. Zoja C, Remuzzi A, Corna D, Perico N, Bertani T, Remuzzi G: Renal protective effect of angiotensin convening enzyme inhibition in aging rats. Am J Med 1996;48:60-63.
36. Kakinuma Y, Kawamura T, Bills T, Yoshida Y, Ichikawa I, Fogo A: Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure. Kidney Int 1992;42:46-55.
37. Remuzzi A, Ruggenenti P, Mosconi L, Pata V, Viberti G, Remuzzi G: Effect of low-dose enalapril on glomerular size-selectivity in human diabetic nephropathy. J Nephrol 1993;6:36-43.
38. Gansevoort RT, de Zeeuw D, de Jong PE: Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition. Kidney Int 1993;44:579-584.
39. Oliver JD, Simons JL, Troy JL, Provoost AP, Brenner BM, Deen WM: Proteinuria and impaired glomerular permselectivity in uninephrectomized fawn-hooded rats. Am J Physiol 1994;267:F917-F925.
40. Morelli E, Loon N, Meyer TW, Peters W, Myers BD: Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990;39:76-82.
41. Mayer G, Lafayette RA, Oliver J, Deen WM, Myers BD, Meyer TW: Effects of angiotensin II receptor blockade on remnant glomerular permselectivity. Kidney Int 1993;43:346-353.
42. Hutchinson FN, Martin VI: Effects of modulation of renal kallikrein-kinin system in the nephrotic syndrome. Am J Physiol 1990;258: F1237-F1244.
43. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A: Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 1994; 45:537-543.
44. Andersen S, Rennke HG, Garcia DL, Brenner BM: Short and long term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989;36:526-536.
45. Ellis EN, Wiegmann TB, Savin VJ: Diminished glomerular capillary hydraulic conductivity precedes morphologic changes in experimental diabetes mellitus in the rat Diabetes 1992;41:1106-1112.
46. Artacho-Perula E, Roldan-Villalobos R, Salcedo-Leal I, Vaamonde-Lemos R: Stereological estimates of volume-weighted mean glomerular volume in streptozotocin-diabetic rats. Lab Invest 1993;68:56-61.
47. O'Brien RC, Cooper ME, Jerums G, Doyle AE: The effect of perindopril and triple therapy in a normotensive model of diabetic nephropathy. Diabetes 1993;42:604-609.
48. Shankland S, Scholey JW: Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney Int 1995;47:782-788.
49. Fogo A, Ichikawa I: Evidence for a pathogenic linkage between glomerular hypertrophy and sclerosis. Am J Kidney Dis 1991;17:666-669.